Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT JOURNEY MEDICAL CORPORATION

Journey Medical Corporation (NASDAQ: DERM)
Listen to this Section


$5.96
-0.2600 ( -4.18% ) 50.9K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Clinical Trial Pipeline Stages


Drug Name Stage
Emrosi™ (Formerly DFD-29)DetailsPapulopustular rosacea Approved

Market Data


Open $5.96
Previous Close $6.22
Volume 50.9K
Market Cap $166.86M
Day Range $5.96 - $6.23
52 Week Range $4.31 - $9.56
Shares Outstanding 27.53M
Change % -4.18%
Net Change ▼ -0.2600
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterB. Riley Securities, Roth Capital, more

Insider Ownership Transactions

Total Amount Purchased: 135,313.00

Date Type Amount Purchased Purchaser
2024-03-25 Buy 30000.00 Smith Justin Adam
2024-03-25 Buy 20000.00 ROSENWALD LINDSAY A MD
2024-02-23 Sale -2450.00 Benesch Joseph
2023-12-08 Sale -2245.00 Paley Jeffrey
2023-11-29 Sale -1745.00 Paley Jeffrey
2023-10-17 Buy 33000.00 Smith Justin Adam
2023-10-10 Buy 15000.00 Paley Jeffrey
2023-09-25 Buy 30000.00 Paley Jeffrey
2023-09-08 Buy 26044.00 Maraoui Claude
2023-09-08 Buy 100000.00 ROSENWALD LINDSAY A MD

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 88 Nov 12, 2025
8-k 8K-related 14 Nov 12, 2025
8-k 8K-related 12 Sep 26, 2025
8-k 8K-related 15 Aug 28, 2025
4 Insider transactions 1 Aug 26, 2025
10-q Quarterly Reports 86 Aug 12, 2025
8-k 8K-related 14 Aug 12, 2025
4 Insider transactions 1 Aug 07, 2025
4 Insider transactions 1 Aug 07, 2025
4 Insider transactions 1 Aug 07, 2025

Latest News


× Before browsing our site, please accept our cookies policy